cerrar
Tagged with P

Product Liability: China
A comprehensive guide to the legal implications around product liability in China. Prepared in association with Fangda Partners, one of China’s…

Traditional Medicines and OTC Products: China
A legal intro to traditional medicines and OTC products in China. Prepared in association with Fangda Partners, one of China’s most prestigious and…

Marketing, Manufacturing, Packaging & Labeling, Advertising:…
A brief overview of the situation regarding marketing, manufacturing, packaging & labeling and advertising within Chinese pharma. Prepared in…

Preclinical and Clinical Trial Requirements: China
The essential requirements for conducting preclinical and clinical trials in China. Prepared in association with Fangda Partners, one of China’s…

Regulatory, Pricing and Reimbursement: China
An intro to the regulatory, pricing and reimbursement scenario for pharmaceuticals in China. Prepared in association with Fangda Partners, one of…

China Pharma News: Fosun Sales up 20%; MNC Price Manoeuvres Lead…
The latest news from Chinese pharma, including Fosun Pharma’s 2021 interim results; how AstraZeneca, Bayer, Eli Lilly, Merck & Co., Novartis,…

Spain Enters the COVID-19 Vaccine Race Through Animal Health…
The Spanish pharma industry has entered the race to develop COVID-19 vaccines through an unexpected contender: an animal health company. HIPRA,…

Top 10 Pharma Companies in Indonesia
The top 10 biggest pharma companies in Indonesia for 2019 ranked by market share, according to Farmasiindustri.com. Top of the pile is Dexa Medica,…

Marco Lee – Vice-President & General Manager, APAC,…
Marco Lee, APAC head for medical device firm Avanos explains how the company's products are catered to patient needs in the region and talks through…

Ireland Pharma News: Abbott Splashes the Cash on New R&D…
The latest news from Irish pharma, including a big new R&D investment for Abbott; contact lens giant Bausch & Lomb’s EUR 90 million…

Top 2021 Insights from Global Regulators
Over the past 12 months, PharmaBoardroom has spoken to the heads of several key regulatory bodies across the world. While the approval processes for…

Burak Dağlıoğlu – President, Investment Office of the…
The president of the Investment Office of the Presidency of the Republic of Turkey, Burak Dağlıoğlu, outlines the country’s current economic…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here